Mix Vaccine for Metastatic Sarcoma Patients
Clinical trial NCT03357315 · COMPLETED
Trial details
- NCT number
- NCT03357315
- Sponsor
- Fuda Cancer Hospital, Guangzhou
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-30
- Primary completion
- 2018-11-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.